Invo Bioscience Inc Reports Results For The Quarter Ended In March: Earnings Summary

INVO Fertility

17/05/2022 19:12

* INVO Bioscience Inc  INVO.OQ  reported a quarterly
adjusted loss
of 22 cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 25 cents per
share.
    * Revenue fell 76.2% to $162.60 thousand from a year ago; 
analysts expected $244.00 thousand. 
    * INVO Bioscience Inc's reported EPS for the quarter was a
loss
of 23 cents​.
    * The mean earnings estimate of analysts had fallen by
about 127.3% in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * INVO Bioscience Inc shares had fallen by 40.9% this
quarter and
lost 53.2% so far this year.
    * The company reported a quarterly loss of $2.77 million.
    * Wall Street's median 12-month price target for INVO
Bioscience
Inc is $4.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 17 at 06:12 p.m.  ​All
figures in US dollars unless otherwise stated